Blood pressure control in dialysis patients: importance of the lag phenomenon.
Failure by the world dialysis community to understand and use the dry-weight method of blood pressure (BP) control has resulted in an increasing incidence of treatment-resistant hypertension, which remains the principal cause of cardiovascular morbidity and mortality. This failure may in part be because the relationship between the extracellular volume (ECV) and BP is not simple and linear, but complex, because of a lag of several weeks between the normalization of the time-averaged ECV and the decrease in BP. Another cause for this failure may be the unwillingness to taper and stop all antihypertensive medications during the transition from hypertension to normotension. In this report, we describe in detail the lag phenomenon, document its presence during treatment in other populations, and describe how this knowledge is used in the application of the dry-weight method of drug-free BP control in the dialysis population.
Charra
B
B
Centre de rein artificiel, Tassin, France. bcharra@aol.com
Bergström
J
J
Scribner
B H
BH
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology*; D001834:Body Water / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D003404:Creatinine / Q000097:blood; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D004351:Drug Resistance; D005110:Extracellular Space / Q000502:physiology; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D015994:Incidence; D006435:Renal Dialysis; D015431:Weight Loss
D000959:Antihypertensive Agents; D004232:Diuretics; D003404:Creatinine